Current Hypertension Reports

, Volume 14, Issue 5, pp 432–441 | Cite as

Perioperative Hypertension: Defining At-Risk Patients and Their Management

Antihypertensive Therapy: Renal Injury (MR Weir and GL Bakris, Section Editors)

Abstract

Hypertension is an extremely pervasive condition that affects a large percentage of the world population. Although guidelines exist for the treatment of the patient with elevated blood pressure, there remains a paucity of literature and accepted guidelines for the perioperative evaluation and care of the patient with hypertension who undergoes either cardiac or noncardiac surgery. Of particular importance is defining the patients most vulnerable to complications and the indications for immediate and rapid antihypertensive treatment and/or cancellation of surgery to reduce these risks in each of the three perioperative settings: preoperative, intraoperative, and postoperative. This review also examines the parenteral antihypertensive medications most commonly administered in the perioperative setting.

Keywords

Hypertension Perioperative hypertension Preoperative hypertension Intraoperative hypertension Postoperative hypertension Stage 1 hypertension Stage 2 hypertension Hypertensive crisis Parenteral antihypertensive medication ACE inhibitor β-Adrenergic blocking agent Calcium channel blocker Arteriolar vasodilation Venodilation Reflex tachycardia Nitroprusside Nitroglycerin Enalaprilat Hydralazine Fenoldopam Esmolol Labetalol Nicardipine Clevidipine 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    The world health statistics 2012 report. Available at http://www.who.int/research/en/index.html. Accessed May 2012.
  2. 2.
    Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.Google Scholar
  3. 3.
    Erstad BL, Barletta JF. Treatment of hypertension in the perioperative patient. Ann Pharmacother. 2000;34:66–79.PubMedCrossRefGoogle Scholar
  4. 4.
    • Varon J and Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008;4(3):615–627. This reference is of importance as it nicely reviews management strategies of perioperative hypertension.PubMedGoogle Scholar
  5. 5.
    Skarvan K. Perioperative hypertension: new strategies for management. Curr Opin Anaesthesiol. 1998;11(1):29–35.PubMedCrossRefGoogle Scholar
  6. 6.
    Hanada S, Kawakami H, Goto T, et al. Hypertension and anesthesia. Curr Opin Anaesthesiol. 2006;19:315–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Howell SJ, Sear JW, Foex P. Hypertension, hypertensive heart disease, and perioperative cardiac risk. Br J Anaesth. 2004;92:570–83.PubMedCrossRefGoogle Scholar
  8. 8.
    Feneck R. Drugs for the perioperative control of hypertension: current issues and future directions. Drugs. 2007;67(14):2023–44.PubMedCrossRefGoogle Scholar
  9. 9.
    • Marik PE and Varon J. Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth. 2009;21:220–229. This reference is of importance as it focuses on commonly used parenteral antihypertensive agents used in the management of perioperative hypertension. PubMedCrossRefGoogle Scholar
  10. 10.
    Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart. 2001;85:342–50.PubMedCrossRefGoogle Scholar
  11. 11.
    Gravlee GP. Perioperative hypertension. Semin Anesth Perioperat Med Pain. 1998;17(2):87–92.CrossRefGoogle Scholar
  12. 12.
    • Ahuja, K and Charap MH. Management of perioperative hypertensive urgencies with parenteral medications. J Hosp Med. 2010;5:E11–E16. This reference is of importance as it focuses on parenteral antihypertensive agents in the management of hypertensive urgency in the perioperative setting. PubMedCrossRefGoogle Scholar
  13. 13.
    Prys-Roberts C, Meloche R, Foex P. Studies of anaesthesia in relation to hypertension: cardiovascular responses of treated and untreated patients. Br J Anaesth. 1971;43:122–37.PubMedCrossRefGoogle Scholar
  14. 14.
    Prys-Roberts C, Greene LT, Meloche R, et al. Studies of anaesthesia in relation to hypertension: haemodynamic consequences of induction and endotracheal intubation. Br J Anaesth. 1971;43:531–47.PubMedCrossRefGoogle Scholar
  15. 15.
    Howell SJ, Sear YM, Yeates D, et al. Hypertension, admission blood pressure and perioperative cardiovascular risk. Anaesthesia. 1996;51:1000–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation. 2007;116:e418–500.PubMedCrossRefGoogle Scholar
  17. 17.
    Weksler N, Klein M, Szendro G, et al. The dilemma of immediate preoperative hypertension: to treat and operate, or to postpone surgery? J Clin Anesth. 2003;15:179–83.PubMedCrossRefGoogle Scholar
  18. 18.
    Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology. 1994;81:299–307.PubMedCrossRefGoogle Scholar
  19. 19.
    Brabant SM, Bertrand M, Eyraud D, et al. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg. 1999;89:1388–92.PubMedGoogle Scholar
  20. 20.
    • Bisognano JD and Fong MW. Perioperative management of hypertension. In: Izzo JL, Black HR, Sica DA, editors. Hypertension primer: the essentials of high blood pressure. Dallas, Texas: Lippincott Williams & Wilkins; 2008 553–556. This reference is of importance as it describes the common causes of perioperative hypertension and the appropriate treatment for the preoperative, intraoperative, and postoperative settings. Google Scholar
  21. 21.
    Nunnelee JD, Spaner SD. Assessment and nursing management of hypertension in the perioperative period. J Perianesthes Nurs. 2000;15(3):163–8.CrossRefGoogle Scholar
  22. 22.
    Cohn JN, Franciosa JA, Francis GS, et al. Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study. N Engl J Med. 1982;306:1129–35.PubMedCrossRefGoogle Scholar
  23. 23.
    Levy JH. Treatment of perioperative hypertension. Anesthesiol Clin. 1999;17(3):567–79.CrossRefGoogle Scholar
  24. 24.
    Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955–60.PubMedCrossRefGoogle Scholar
  25. 25.
    Wilson DJ, Wallin JD, Vlachakis ND, et al. Intravenous labetalol in the treatment of hypertension and hypertensive emergencies. Am J Cardiol. 1988;62:1062–7.CrossRefGoogle Scholar
  26. 26.
    IV Nicardipine Study Group. Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. Chest. 1991;99:393–8.CrossRefGoogle Scholar
  27. 27.
    • Aronson S, Dyke CM, Stierer KA, et al. The ECLIPSE Trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107:1110–1121. This reference is important as it focuses on clevidipine and its effectivness in controlling perioperative hypertension. PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of CardiologyUniversity of Rochester Medical CenterRochesterUSA

Personalised recommendations